Shoshana buys VRTX 93.12: Vertex Pharmaceuticals Upgraded to âBuyâ by Goldman Sachs (VRTX)
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by stock analysts at Goldman Sachs from a âneutralâ rating to a âbuyâ rating in a report issued on Friday, TheFlyOnTheWall.com reports. Shares of Vertex Pharmaceuticals (NASDAQ:VRTX) opened at 91.55 ... ...
18 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home